All In Biotech

Drug Trial Radar · NCT06679985

A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma

A Randomized Phase 2 Study of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma

Last checked: Nov 20, 2026Latest source record: Jul 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

72

Planned (sponsor's estimate)

Start

Dec 20, 2024

Primary completion

Sep 2027

Study completion Sep 2027

Sponsor

Lead sponsor
Coherus Oncology, Inc.Industry
Sponsor type
Industry
First posted
Nov 8, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main goals of this study are to evaluate the safety and efficacy of casdozokitug in combination with toripalimab plus bevacizumab and to define a recommended dose for casdozokitug in combination with toripalimab plus bevacizumab.

Conditions

  • Hepatocellular Carcinoma

Interventions

  • CasdozokitugDrug

    Solution for infusion

  • ToripalimabDrug

    Solution for infusion

  • BevacizumabDrug

    Solution for infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants with Treatment-emergent Adverse Events (TEAEs)Time frame: From date of first dose to 90 days after date of last dose (Up to approximately 27 months)
  2. Objective Response Rate (ORR) by Investigator Review According to Response Evaluation Criteria in Solid Tumors (RECIST) v1.1Time frame: Up to approximately 2 years

Locations

44 sites in 6 countries. Site status is shown where the registry gives one.

  • Mayo Clinic - Scottsdale

    Scottsdale, Arizona

  • University of Arizona - Cancer Center

    Tucson, Arizona

  • Beverly Hills Cancer Center

    Beverly Hills, California

  • City of Hope

    Duarte, California

  • City of Hope at Irvine Lennar

    Irvine, California

  • Cancer & Blood Specialty Clinic

    Lakewood, California

  • USC Norris Comprehensive Cancer Center

    Los Angeles, California

  • Sarcoma Oncology Center

    Santa Monica, California

  • Mayo Clinic - Jacksonville

    Jacksonville, Florida

  • The Winship Cancer Institute Emory University

    Atlanta, Georgia

  • Mountain States Tumor Institute at St. Luke's Regional Medical Center

    Boise, Idaho

  • University of Kansas Cancer Center

    Kansas City, Kansas

  • UofL Health Brown Cancer Center

    Louisville, Kentucky

  • University of Mississippi Medical Center

    Jackson, Mississippi

  • Christus St. Vincent Regional Medical Center

    Santa Fe, New Mexico

  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center

    New York, New York

  • Montefiore Medical Center

    The Bronx, New York

  • University of North Carolina (UNC) - Chapel Hill

    Chapel Hill, North Carolina

  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio

  • The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solovev Research Institute (OSUCCC - James)

    Columbus, Ohio

  • University of Pittsburgh Medical Center (UPMC) - Hillman Cancer Center

    Pittsburgh, Pennsylvania

  • Prisma Health Cancer Institute

    Greenville, South Carolina

  • Virginia Cancer Specialists

    Fairfax, Virginia

  • Virginia Oncology Associates

    Norfolk, Virginia

  • UW Carbone Cancer Center - Cancer Connect

    Madison, Wisconsin

  • St Vincent's Hospital Sydney

    Darlinghurst, Australia

  • Linear Clinical Research

    Nedlands, Australia

  • Royal Brisbane and Women's Hospital

    Herston, Brisbane, Australia

  • Bankstown-Lidcombe Hospital

    Bankstown, New South Wales, Australia

  • Monash Health

    Melbourne, Victoria, Australia

  • Sunnybrook Health Sciences Centre - Bayview Campus

    Toronto, Ontario, Canada

  • Princess Margaret Hospital

    Toronto, Ontario, Canada

  • Humanity & Health Clinical Trial Centre

    Hong Kong, Hong Kong

  • Prince of Wales Hospital

    Shatin, New Territories, Hong Kong

  • Queen Mary Hospital

    Hong Kong, Pok Fu Lam, Hong Kong

  • National Cancer Centre Singapore

    Singapore, Singapore

  • Tan Tock Seng Hospital

    Singapore, Singapore

  • Curie Oncology

    Singapore, Singapore

  • Chi Mei Medical Center

    Tainan, Taiwan

  • Linkou Chang Gung Memorial Hospital (CGMHLK)

    Taoyuan City, Taiwan

Showing 40 of 44 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.